Hyderabad-based Hetero gets DCGI nod to manufacture, market Molnupiravir capsules
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreDetails
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreDetailsHyderabad: Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of antiretroviral drugs, on Wednesday announced ...
Read moreDetailsNew Delhi: Four domestic pharma firms – Cipla, Jubilant Life Sciences, Hetero and Mylan – have entered into non-exclusive licensing agreements ...
Read moreDetails
Aakar Patel I walk out of my house and onto the street and look around. Not much is different from...
Read moreDetails
Syed Ali Murtaza Rizvi’s decision to hang up his boots eight years ahead of time has clearly rattled the Telangana...
Read moreDetails
By Yuen Yuen Ang Conflicts, trade wars, inequality, and democratic decay fill today’s headlines. Each crisis appears to be feeding...
Read moreDetails
By Senem Aydın-Düzgit US President Donald Trump’s ferocious assault on American institutions over the last nine months is a particularly...
Read moreDetails
